创新药新增适应症的医保准入国际经验研究

Research on the International Experience of Medical Insurance Access for New Indications of Innovative Drugs

本文运用国际专家访谈法和文献资料整理法,系统梳理、分析比较日本、韩国、荷兰、法国、瑞士五个典型国家药物新增适应症医保准入经验做法,在总结借鉴国际经验的基础上,对我国创新药新增适应症医保准入流程与支付标准提供参考建议。

This study systematically expounds and analyzes the experience of medical insurance access for new indications of drugs in five typical countries with international expert interview and literature review,including Japan,South Korea,the Netherlands,France,and Switzerland.Based on the international experience,this study puts forward suggestions on national medical insurance access process and payment standard for new indications application in China.